Fundz

Bionaut Labs Closes $43M In Series B Led By Khosla Ventures To Advance First-In-Class Micro-Robotic Technology And Remove Barriers To Treat Rare And Debilitating Diseases

PRIVATENov 28, 2022

Amount Raised

$43 Million

Round Type

Series B

Los AngelesBiotechnologyHealth CareMedical

Investors

Revolution VCBold Capital PartnersUpfront VenturesVenturesGisev Family VenturesDolby Family VenturesSixty Degree CapitalKhosla Ventures

Description

Bionaut Labs, the company that uses microscale robots to revolutionize the treatment of central nervous system (CNS) diseases and disorders, today announced $43.2M in a Series B round of financing led by Khosla Ventures, bringing the company’s total financing raised to date to $63.2 million. Also participating in the round are new investors Deep Insight, OurCrowd, PSPRS, Sixty Degree Capital, Dolby Family Ventures, GISEV Family Ventures, What if Ventures, Tintah Grace and Gaingels, along with all existing investors - Upfront Ventures, BOLD Capital Partners, Revolution VC, and Compound.

Who else raised in Medical and Biotechnology around the same time

Companies in the same sectors as Bionaut Labs that raised within 45 days of this round, from Fundz verified event records.

  • Streamex Corp. raised $1.8M (Seed) on January 10, 2023.
  • Medix Infusion raised $35M (Series B) on January 10, 2023.
  • Monogram Health raised $375M (Funding Round) on January 9, 2023.
  • MedX Health raised an undisclosed amount (Convertible Note) on January 6, 2023.
  • Amolyt Pharma raised $138M (Series C) on January 6, 2023.
  • Volta Medical raised $38M (Series B) on January 5, 2023.

Who to call at Bionaut Labs, and when

A new round usually means Bionaut Labs is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Bionaut Labs raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Bionaut Labs, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Bionaut Labs. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Bionaut Labs

Location

Los Angeles, California, United States

About

Bionaut Labs is a biotech company pioneering precision micro-technology with the deployment of microscale robots (Bionauts™), to remove the barriers of localized treatment and detection of diseases. Magnetic propulsion-controlled Bionauts navigate to deep locations in the human body and brain safely and precisely through non-linear 3D trajectories, making Bionaut Labs the first to access the midbrain through previously inaccessible anatomical routes. Bionauts can perform localized treatment, detection and precise medical procedures to deliver outcomes that were previously unattainable. The FDA has granted Bionaut Labs a Humanitarian Use Device designation for BNL-201, a micro-robot design to treat Dandy Walker Malformation, and an Orphan Drug Designation for BNL 101, a drug-device combination for treatment of malignant glioma. Led by a world-class team of medical, engineering, and drug development experts, Bionaut Labs’ is headquartered in Los Angeles, California, with additional R&D sites in Israel and at the Max Planck Institute in Germany. For more information, please visit www.bionautlabs.com.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Bionaut Labs raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Bionaut Labs's next move

See what Strategic adds

Funding Insights

What this usually means
Timeline to next round
Series B companies typically work for 15-20 months before raising new capital
Growth expectations
Series B companies are expected to scale rapidly and expand market reach

Bionaut Labs raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.